Nuveen’s Axcelis ACLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $15.4M | Buy |
81,142
+9,757
| +14% | +$1.45M | ﹤0.01% | 1432 |
|
|
2026
Q1 | $6.64M | Buy |
71,385
+992
| +1% | +$87.8K | ﹤0.01% | 1768 |
|
|
2025
Q4 | $5.66M | Sell |
70,393
-2,889
| -4% | -$242K | ﹤0.01% | 1854 |
|
|
2025
Q3 | $7.16M | Sell |
73,282
-927
| -1% | -$74.7K | ﹤0.01% | 1735 |
|
|
2025
Q2 | $5.17M | Sell |
74,209
-15,327
| -17% | -$874K | ﹤0.01% | 1860 |
|
|
2025
Q1 | $4.45M | Sell |
89,536
-78,034
| -47% | -$4.93M | ﹤0.01% | 1981 |
|
|
2024
Q4 | $11.7M | Sell |
167,570
-139,753
| -45% | -$11.6M | ﹤0.01% | 1516 |
|
|
2024
Q3 | $32.2M | Sell |
307,323
-433
| -0.1% | -$50.6K | 0.01% | 887 |
|
|
2024
Q2 | $43.8M | Buy |
307,756
+27,859
| +10% | +$3.21M | 0.01% | 684 |
|
|
2024
Q1 | $31.2M | Sell |
279,897
-89
| -0% | -$10.6K | 0.01% | 890 |
|
|
2023
Q4 | $36.3M | Buy |
279,986
+42,605
| +18% | +$5.87M | 0.01% | 774 |
|
|
2023
Q3 | $38.7M | Buy |
237,381
+57,594
| +32% | +$10.1M | 0.01% | 674 |
|
|
2023
Q2 | $33M | Buy |
179,787
+5,772
| +3% | +$831K | 0.01% | 769 |
|
|
2023
Q1 | $23.2M | Buy |
174,015
+14,894
| +9% | +$1.75M | 0.01% | 945 |
|
|
2022
Q4 | $12.6M | Buy |
159,121
+40,718
| +34% | +$2.87M | ﹤0.01% | 1342 |
|
|
2022
Q3 | $7.17M | Sell |
118,403
-2,128
| -2% | -$137K | ﹤0.01% | 1685 |
|
|
2022
Q2 | $6.61M | Sell |
120,531
-440
| -0.4% | -$25.5K | ﹤0.01% | 1769 |
|
|
2022
Q1 | $9.5M | Sell |
120,971
-2,534
| -2% | -$173K | ﹤0.01% | 1673 |
|
|
2021
Q4 | $7.75M | Sell |
123,505
-9,545
| -7% | -$566K | ﹤0.01% | 1839 |
|
|
2021
Q3 | $6.5M | Sell |
133,050
-6,115
| -4% | -$266K | ﹤0.01% | 2071 |
|
|
2021
Q2 | $5.63M | Sell |
139,165
-8,226
| -6% | -$341K | ﹤0.01% | 2183 |
|
|
2021
Q1 | $6.06M | Sell |
147,391
-2,159
| -1% | -$80.5K | ﹤0.01% | 2080 |
|
|
2020
Q4 | $4.36M | Sell |
149,550
-131,242
| -47% | -$3.4M | ﹤0.01% | 2146 |
|
|
2020
Q3 | $6.18M | Sell |
280,792
-173,395
| -38% | -$4.42M | ﹤0.01% | 1807 |
|
|
2020
Q2 | $12.6M | Buy |
454,187
+173,496
| +62% | +$4.23M | 0.01% | 1325 |
|
|
2020
Q1 | $5.14M | Buy |
280,691
+118,114
| +73% | +$2.74M | ﹤0.01% | 1701 |
|
|
2019
Q4 | $3.92M | Buy |
162,577
+17,228
| +12% | +$363K | ﹤0.01% | 2118 |
|
|
2019
Q3 | $2.48M | Buy |
145,349
+3,604
| +3% | +$57.6K | ﹤0.01% | 2307 |
|
|
2019
Q2 | $2.13M | Buy |
141,745
+126,268
| +816% | +$2.26M | ﹤0.01% | 2405 |
|
|
2019
Q1 | $311K | Buy |
15,477
+3,423
| +28% | +$69.5K | ﹤0.01% | 928 |
|
|
2018
Q4 | $215K | Sell |
12,054
-12,502
| -51% | -$222K | ﹤0.01% | 942 |
|
|
2018
Q3 | $483K | Sell |
24,556
-28,072
| -53% | -$578K | ﹤0.01% | 867 |
|
|
2018
Q2 | $1.04M | Sell |
52,628
-854
| -2% | -$18.8K | 0.01% | 725 |
|
|
2018
Q1 | $1.32M | Buy |
+53,482
| New | +$1.41M | 0.01% | 696 |
|
|
2015
Q4 | – | Sell |
-2,257
| Closed | -$9.74M | – | 1518 |
|
|
2015
Q3 | $9.74M | Buy |
+2,257
| New | +$27.5K | 0.06% | 337 |
|
Other funds holding ACLS
RP
Nuveen's ACLS Position: Q2 2026 in Review
Nuveen increased its Axcelis (ACLS) stake by 14% in Q2 2026, buying an estimated $1.45M and bringing the position to 81,142 shares worth $15.4M. The position accounts for ﹤0.01% of the portfolio, ranked #1432.
Nuveen first reported a position in ACLS in Q3 2015 and has held it in 35 quarters since. The position peaked at $43.8M in Q2 2024. 441 funds tracked by Wall St. Rank hold ACLS as of Q2 2026.
- Nuveen held 81,142 shares of Axcelis worth $15.4M as of Q2 2026.
- Nuveen bought 9,757 Axcelis shares in Q2 2026, an estimated $1.45M.
- Axcelis made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #1432 holding.
- Nuveen first reported a position in Axcelis in Q3 2015 and has held it in 35 quarters since.
- Nuveen's Axcelis position peaked at $43.8M in Q2 2024.
- 441 funds tracked by Wall St. Rank held Axcelis as of Q2 2026.
Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.